what happens when you switch from semaglutide to tirzepatide and key differences, weight loss results (2026) Experiences switching from semaglutide to

In addition, there is obvious hyperpigmentation, but no junctional activity

While these drugs can greatly assist with weight loss, they cannot substitute for healthy habits.

REDEFINE 1: Efficacy and safety of cagrilintide monotherapy for weight management

Editorial: risks and benefits of adjuvants to cancer therapies

Telehealth wins in speed

This blog, based on IQVIAs 18th March 2026 webinar on the future of the Obesity Medicines market, looks ahead to the next phase of that transformation, examining how the obesity market evolves from 2026 to 2030, and how the drivers of success shift from rapid adoption to differentiation, longterm performance and systemlevel impact